StorytellERdoc
JULY 10, 2014
When thinking about emergency room settings, even, one can easily correlate the words of Webster to what one would necessitate to be a situation requiring emergency medical treatment. When a critical illness or injury occurs, then, we should all be thankful that we live within a society where emergent, life-saving medical care is available.
Today's Hospitalist
APRIL 24, 2025
Key takeaways: Admission delays from the ED can adversely affect mortality, length of stay, medical errors and quality of care. Those interventions included standardizing both bed assignments and nursing handoffs while having ED providers—not an inpatient team—enter skeletal orders when deciding to admit a patient.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MARCH 7, 2024
Tobolowsky & Véronique Li, Senior Medical Device Regulation Expert & David B. Moreover, DMCs are being used in trials of modest size and in the context of increased globalization of medical product development. The 2006 guidance noted that these would be “rare cases” limited to “specific issues of urgent concern.”
Medical Xpress
FEBRUARY 6, 2023
A new study has found that patients are increasingly likely to discuss mental health concerns with the doctor they often know best: their primary care physician.
PEMBlog
MAY 17, 2023
Furthermore, the connection between physical and functional symptoms is inextricably linked in many patients. Why then do we persist with the “is it medical/organic or psych” question? Diagnostic yield of head CT in pediatric emergency department patients with acute psychosis or hallucinations. Government.
FDA Law Blog
DECEMBER 12, 2022
Shapiro — Last summer, FDA published a draft guidance, Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations (July 29, 2022) setting forth a proposal for new recommended patient‑directed labeling. The approved devices already have patient‑directed labeling that FDA has approved. By Jeffrey K.
FDA Law Blog
NOVEMBER 1, 2023
Lenz, Principal Medical Device Regulation Expert & Sophia R. Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Gaulkin & Jeffrey N.
Expert insights. Personalized for you.
100 
Let's personalize your content